Invention Grant
- Patent Title: Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis
-
Application No.: US15189062Application Date: 2016-06-22
-
Publication No.: US10053687B2Publication Date: 2018-08-21
- Inventor: Philip Felgner , Xiaowu Liang , Maria Laura Gennaro
- Applicant: Immport Therapeutics, Inc.
- Applicant Address: US CA Irvine
- Assignee: Immport Therapeutics, Inc.
- Current Assignee: Immport Therapeutics, Inc.
- Current Assignee Address: US CA Irvine
- Agency: Umberg Zipser LLP
- Main IPC: A61K39/15
- IPC: A61K39/15 ; C12N15/10 ; A61K39/015 ; A61K39/02 ; A61K39/04 ; A61K39/118 ; A61K39/245 ; A61K39/285 ; A61K39/385 ; C07K14/005 ; G01N33/566 ; A61K39/12 ; G01N33/569 ; G01N33/68 ; A61K39/00

Abstract:
Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen M. tuberculosis and their use in vaccines, therapeutic agents, and various diagnostic tests. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter.
Public/Granted literature
- US20170023586A1 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis Public/Granted day:2017-01-26
Information query